Financials
- Market Capitalization 470.41 M
- Employee 17
- Founded 2004
- CEO N/A
- Website www.relmada.com
- Headquarter Nevada, United States
- FIGI BBG003MKSL16
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-3.33
市销率
-2 407.45
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 2935 | EVMN Evommune, Inc. Common Stock | 13.42 USD | -0.07% | -5.16% | +20.79% | -22.52% | 487.04 M USD | ||
| 2948 | PRTA Prothena Corporation plc - Ordinary Shares | 9.31 USD | +2.42% | +0.32% | +7.75% | +12.58% | 477.95 M USD | ||
| 2953 | RZLT Rezolute, Inc. - Common Stock | 4.74 USD | -4.82% | -5.58% | -3.85% | -34.98% | 456.43 M USD | ||
| 2960 | PBYI Puma Biotechnology Inc - Common Stock | 9.09 USD | -1.62% | -1.52% | +14.20% | +80.72% | 469.23 M USD |